HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.

Abstract
The hepatic stellate cells (HSCs) play a significant role in the onset of liver fibrosis, which can be treated by the inhibition and reversal of HSC activation. The RNA interference-mediated TLR4 gene silencing might be a potential therapeutic approach for liver fibrosis. The crucial challenge in this method is the absence of an efficient delivery system for the RNAi introduction in the target cells. HSCs have an enhanced capacity of vitamin A intake as they contain retinoic acid receptors (RARs). In the current study, we developed cationic liposomes modified with vitamin A to improve the specificity of delivery vehicles for HSCs. The outcome of this study revealed that the VitA-coupled cationic liposomes delivered the TLR4 shRNA to aHSCs more efficiently, as compared to the uncoupled cationic liposomes, both in the in vitro and in vivo conditions. Besides, as evident from the outcome of this study, the TLR4 gene silencing inhibited the HSCs activation and attenuated the liver fibrosis via the NF-κB transcriptional inactivation, pro-inflammatory cytokines secretion and reactive oxygen species (ROS) synthesis. Thus, the VitA-coupled liposomes encapsulated with the TLR4-shRNA might prove as an efficient therapeutic agent for liver fibrosis.
AuthorsYuwei Zhang, Yang Li, Tong Mu, Nanwei Tong, Ping Cheng
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 25 Issue 2 Pg. 1299-1313 (01 2021) ISSN: 1582-4934 [Electronic] England
PMID33336563 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Chemical References
  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • Liposomes
  • NF-kappa B
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Toll-Like Receptor 4
  • Vitamin A
  • DNA
  • NADPH Oxidases
Topics
  • Animals
  • Cytokines (metabolism)
  • DNA (metabolism)
  • Disease Progression
  • Extracellular Matrix (metabolism)
  • Female
  • Gene Silencing
  • Hepatic Stellate Cells (metabolism)
  • Inflammation Mediators (metabolism)
  • Lipopolysaccharides
  • Liposomes
  • Liver Cirrhosis (pathology, therapy)
  • Mice, Inbred C57BL
  • Mitochondria (metabolism)
  • NADPH Oxidases (metabolism)
  • NF-kappa B (genetics, metabolism)
  • RNA, Small Interfering (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Tissue Distribution
  • Toll-Like Receptor 4 (metabolism)
  • Transcription, Genetic
  • Vitamin A (metabolism, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: